Ion Channels: New Actors Playing in Chemotherapeutic Resistance

In the battle against cancer cells, therapeutic modalities are drastically limited by intrinsic or acquired drug resistance. Resistance to therapy is not only common, but expected: if systemic agents used for cancer treatment are usually active at the beginning of therapy (i.e., 90% of primary breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kischel, Philippe, Girault, Alban, Rodat-Despoix, Lise, Chamlali, Mohamed, Radoslavova, Silviya, Abou Daya, Hiba, Lefebvre, Thibaut, Foulon, Arthur, Rybarczyk, Pierre, Hague, Frédéric, Dhennin-Duthille, Isabelle, Gautier, Mathieu, Ouadid-Ahidouch, Halima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468599/
https://www.ncbi.nlm.nih.gov/pubmed/30884858
http://dx.doi.org/10.3390/cancers11030376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468599/
https://www.ncbi.nlm.nih.gov/pubmed/30884858
http://dx.doi.org/10.3390/cancers11030376

Ejemplares similares